Long non-coding RNA CRALA is associated with poor response to chemotherapy in primary breast cancer.

Yudong LiBaoxiao WangHongna LaiShunying LiQiuting YouYichao FangQian LiYujie Liu

Published in: Thoracic cancer (2017)

The study findings indicate that CRALA expression may be an important biomarker for predicting the clinical response to chemotherapy and prognosis in breast cancer patients. It is possible to target CRALA to reverse chemoresistance in breast cancer patients.

Keyphrases

long non coding rna
poor prognosis
locally advanced
squamous cell carcinoma
radiation therapy
rectal cancer